These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 16762882)

  • 1. [Expression of TGFbeta1 and its type I receptors ALK1 and ALK5 mRNA in brain arteriovenous malformation].
    Chen GZ; Li TL; Quan W; Huang T; Zhao QP; Wang JQ; Duan CZ; Wang QJ; Jiang XD
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 May; 26(5):675-7. PubMed ID: 16762882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activin Receptor-Like Kinase Receptors ALK5 and ALK1 Are Both Required for TGFβ-Induced Chondrogenic Differentiation of Human Bone Marrow-Derived Mesenchymal Stem Cells.
    de Kroon LM; Narcisi R; Blaney Davidson EN; Cleary MA; van Beuningen HM; Koevoet WJ; van Osch GJ; van der Kraan PM
    PLoS One; 2015; 10(12):e0146124. PubMed ID: 26720610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of vascular endothelial growth factor is coordinately regulated by the activin-like kinase receptors 1 and 5 in endothelial cells.
    Shao ES; Lin L; Yao Y; Boström KI
    Blood; 2009 Sep; 114(10):2197-206. PubMed ID: 19506300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGFbeta1 induces vasculogenesis and inhibits angiogenic sprouting in an embryonic stem cell differentiation model: respective contribution of ALK1 and ALK5.
    Mallet C; Vittet D; Feige JJ; Bailly S
    Stem Cells; 2006 Nov; 24(11):2420-7. PubMed ID: 17071858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ALK1 opposes ALK5/Smad3 signaling and expression of extracellular matrix components in human chondrocytes.
    Finnson KW; Parker WL; ten Dijke P; Thorikay M; Philip A
    J Bone Miner Res; 2008 Jun; 23(6):896-906. PubMed ID: 18333754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increase in ALK1/ALK5 ratio as a cause for elevated MMP-13 expression in osteoarthritis in humans and mice.
    Blaney Davidson EN; Remst DF; Vitters EL; van Beuningen HM; Blom AB; Goumans MJ; van den Berg WB; van der Kraan PM
    J Immunol; 2009 Jun; 182(12):7937-45. PubMed ID: 19494318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remodeling retinal neovascularization by ALK1 gene transfection in vitro.
    Li B; Yin W; Hong X; Shi Y; Wang HS; Lin SF; Tang SB
    Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4553-60. PubMed ID: 18829861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thalidomide Reduces Hemorrhage of Brain Arteriovenous Malformations in a Mouse Model.
    Zhu W; Chen W; Zou D; Wang L; Bao C; Zhan L; Saw D; Wang S; Winkler E; Li Z; Zhang M; Shen F; Shaligram S; Lawton M; Su H
    Stroke; 2018 May; 49(5):1232-1240. PubMed ID: 29593101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ALK5- and TGFBR2-independent role of ALK1 in the pathogenesis of hereditary hemorrhagic telangiectasia type 2.
    Park SO; Lee YJ; Seki T; Hong KH; Fliess N; Jiang Z; Park A; Wu X; Kaartinen V; Roman BL; Oh SP
    Blood; 2008 Jan; 111(2):633-42. PubMed ID: 17911384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptible gene single nucleotide polymorphism and hemorrhage risk in patients with brain arteriovenous malformation.
    Jiang N; Li X; Qi T; Guo S; Liang F; Huang Z
    J Clin Neurosci; 2011 Sep; 18(9):1279-81. PubMed ID: 21737283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of Brain Arteriovenous Malformation Through CRISPR/Cas9-Mediated Somatic Alk1 Gene Mutations in Adult Mice.
    Zhu W; Saw D; Weiss M; Sun Z; Wei M; Shaligram S; Wang S; Su H
    Transl Stroke Res; 2019 Oct; 10(5):557-565. PubMed ID: 30511203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonoverlapping expression patterns of ALK1 and ALK5 reveal distinct roles of each receptor in vascular development.
    Seki T; Hong KH; Oh SP
    Lab Invest; 2006 Feb; 86(2):116-29. PubMed ID: 16344855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-specific expression and alternate splicing of messenger ribonucleic acid encoding activin/transforming growth factor-beta receptors in human pituitary adenomas.
    Alexander JM; Bikkal HA; Zervas NT; Laws ER; Klibanski A
    J Clin Endocrinol Metab; 1996 Feb; 81(2):783-90. PubMed ID: 8636304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TGFβ1-mediated PI3K/Akt and p38 MAP kinase dependent alternative splicing of fibronectin extra domain A in human podocyte culture.
    Madne TH; Dockrell MEC
    Cell Mol Biol (Noisy-le-grand); 2018 Apr; 64(5):127-135. PubMed ID: 29729706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct regulation of gene expression in human endothelial cells by TGF-beta and its receptors.
    Wu X; Ma J; Han JD; Wang N; Chen YG
    Microvasc Res; 2006 Jan; 71(1):12-9. PubMed ID: 16405919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone Marrow-Derived Alk1 Mutant Endothelial Cells and Clonally Expanded Somatic Alk1 Mutant Endothelial Cells Contribute to the Development of Brain Arteriovenous Malformations in Mice.
    Shaligram SS; Zhang R; Zhu W; Ma L; Luo M; Li Q; Weiss M; Arnold T; Santander N; Liang R; do Prado L; Tang C; Pan F; Oh SP; Pan P; Su H
    Transl Stroke Res; 2022 Jun; 13(3):494-504. PubMed ID: 34674144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of TGFbeta1 and its signaling components by peripheral lymphocytes in systemic lupus erythematosus.
    Kohut E; Hajdu M; Gergely P; Gopcsa L; Kilián K; Pálóczi K; Kopper L; Sebestyén A
    Pathol Oncol Res; 2009 Jun; 15(2):251-6. PubMed ID: 19020994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the prognostic value of TGF-β superfamily type I receptor and TGF-β type II receptor expression in nasopharyngeal carcinoma using high-throughput tissue microarrays.
    Zhang W; Zeng Z; Fan S; Wang J; Yang J; Zhou Y; Li X; Huang D; Liang F; Wu M; Tang K; Cao L; Li X; Xiong W; Li G
    J Mol Histol; 2012 Jun; 43(3):297-306. PubMed ID: 22391627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. L- and S-endoglin differentially modulate TGFbeta1 signaling mediated by ALK1 and ALK5 in L6E9 myoblasts.
    Velasco S; Alvarez-Muñoz P; Pericacho M; Dijke PT; Bernabéu C; López-Novoa JM; Rodríguez-Barbero A
    J Cell Sci; 2008 Mar; 121(Pt 6):913-9. PubMed ID: 18303046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutational analysis of activin/transforming growth factor-beta type I and type II receptor kinases in human pituitary tumors.
    D'Abronzo FH; Swearingen B; Klibanski A; Alexander JM
    J Clin Endocrinol Metab; 1999 May; 84(5):1716-21. PubMed ID: 10323406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.